The Charles Bronfman Institute for Personalized Medicine

BioMe® BioBank Program

Our Approach

We are channeling the power of genomics and big data to elevate medical decision-making and optimize the customization of health care.

For pharmaceutical and biotech companies, drug development is multifaceted. For doctors, the administration of medical care is complex. For patients, undergoing the right treatment is decisive. 

Personalized medicine is what drives our Institute's research. Help us answer the question being asked by the drug designer, the practitioner, and by patients: “Is this therapy going to work for me?” 

“DNA is the key to unlocking the causes of disease and all of our own personal risks for future ailments,” says Douglas T. Dieterich, MD, Professor of Medicine, Division of Liver Diseases. “It can predict not only ours but our children’s potential problems in time to change the course of disease and history at the same time. Investing your money and your DNA in the Biobank is the best investment you can ever make in you and your family’s health.”

The World's Top 10 Most Innovative Companies in Big Data …Mount Sinai Icahn School of Medicine
For embracing data scientists and supercomputers to build the hospital of the future. …At the heart of Mount Sinai’s efforts are...BioMe, a database of genomic samples from more than 25,000 patients.”

-Fast Company, February 2014

Funded by The Charles Bronfman Institute for Personalized Medicine, BioMe is an electronic medical record-linked biobank that enables researchers to rapidly and efficiently conduct genetic, epidemiologic, molecular, and genomic studies on large collections of research specimens linked with medical information. Learn more about the BioMe tool

BioMe is the only EHR-linked bio and data repository in New York City that performs unrestricted patient enrollment (non-selective in terms of gender, race, ethnicity, age, medical condition, or disease status), leading to a cohort unmatched in ethnic, socio-economic, and medical diversity and ready to be tapped for the broadest variety of biomedical and genetic research possible. Learn more about BioMe

BioMe is a resource for sponsored biomedical and genetic research, and we are attracting interest from biotechnology companies and clinical and academic centers of excellence around the world. Our expansive patient pool will help you uncover information that could be useful in the pursuit of personalized medicine. Learn more about our innovative research approaches

To support comprehensive data management and analysis, the BioMe team created an efficient and integrated pipeline environment called the BioMe Informatics and Genomic Data Analysis Center (BIGDASC). BIGDASC provides access to de-identified phenotypic information in the Biobank Clinical DataMart, which is updated weekly from the Mount Sinai Data Warehouse (MSDW). Learn more details about BioMe

With over 32,000 participants, BioMe Biobank is the largest, most diverse cohort ever ascertained at a single urban medical center resulting in a collection of blood samples, genetic data, and health information used for present and future research projects. BioMe not only allows scientists to gain better understanding of factors that cause disease using genetic information but also empowers participants of BioMe to improve their own health. Learn more about how BioMe helps patients

By volunteering to participate in the BioMe Biobank Program you are contributing to research that may create new means of preventing and treating disorders affecting you, your family, or your friends. Our list of Frequently Answered Questions provides all you need to know. Read the FAQ

Our bi-annual newsletter features bulletins and fascinating facts about genetics, your co-participants, and our programs. Here are the latest issues:

Make a Gift